Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells-Reference-Cited by-同舟云学术

Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells

Published:2013-03-29 Issue:11 Volume:27 Page:2177-2186
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Wei Y,Chen R,Dimicoli S,Bueso-Ramos C,Neuberg D,Pierce S,Wang H,Yang H,Jia Y,Zheng H,Fang Z,Nguyen M,Ganan-Gomez I,Ebert B,Levine R,Kantarjian H,Garcia-Manero G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201391.pdf

Reference60 articles.

1. Tefferi A, Vardiman JW . Myelodysplastic syndromes. N Engl J Med. 2009; 361: 1872–1885.

2. Garcia-Manero G, Fenaux P . Hypomethylating agents and other novel strategies in myelodysplastic syndromes. J Clin Oncol 2011; 29: 516–523.

3. Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Perez WS, Anasetti C et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood 2004; 104: 579–585.

4. Slape C, Lin YW, Hartung H, Zhang Z, Wolff L, Aplan PD . NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men. J Natl Cancer Inst Monogr 2008, 64–68.

5. Schanz J, Steidl C, Fonatsch C, Pfeilstocker M, Nosslinger T, Tuechler H et al. Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system. J Clin Oncol 2011; 29: 1963–1970.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of Jumonji domain-containing protein D3 in inflammatory diseases;Journal of Pharmaceutical Analysis;2024-09

2. JMJD3 mediated senescence is required to overcome stress induced hematopoietic defects;2024-08-09

3. Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer;Frontiers in Hematology;2024-02-15

4. Targeting lysine demethylase 6B ameliorates ASXL1 truncation–mediated myeloid malignancies in preclinical models;Journal of Clinical Investigation;2024-01-02

5. KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition;Leukemia;2023-01-31